Hemispherx Biopharma Files NDA for Ampligen
FDA news, VA -
Hemispherx Biopharma has filed a new drug application (NDA) with the FDA for Ampligen, its experimental therapeutic to treat chronic fatigue syndrome. …
Source: FDA news
Hemispherx Biopharma Files NDA for Ampligen
FDA news, VA -
Hemispherx Biopharma has filed a new drug application (NDA) with the FDA for Ampligen, its experimental therapeutic to treat chronic fatigue syndrome. …
Source: FDA news
Previous post: HEALTH BRIEFS – USA Weekend
Next post: BC woman laughs in the face of her disorder – Battle Creek Enquirer